Published in Transpl Int on March 21, 2013
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis. Am J Transplant (2015) 1.44
Management of hepatitis C infection before and after liver transplantation. World J Gastroenterol (2015) 0.85
Challenges of recurrent hepatitis C in the liver transplant patient. World J Gastroenterol (2014) 0.77
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86
Architecture of the RNA polymerase II-TFIIF complex revealed by cross-linking and mass spectrometry. EMBO J (2010) 3.40
The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics. Cell (2010) 3.26
Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score. Ann Surg (2014) 2.09
Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer (2008) 2.01
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significance. Leuk Lymphoma (2014) 1.94
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score. Spine (Phila Pa 1976) (2011) 1.77
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol (2008) 1.70
Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69
Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture. Sci Transl Med (2013) 1.65
Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation (2009) 1.63
Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl (2006) 1.56
Pregnancy in primary sclerosing cholangitis. Gut (2011) 1.55
Dynamics of neurological deficit after surgical decompression of symptomatic vertebral metastases. Spine (Phila Pa 1976) (2009) 1.55
Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study. Liver Transpl (2009) 1.47
Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg (2002) 1.45
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study. Ann Surg (2012) 1.41
In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor. Transplantation (2012) 1.39
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J Hepatol (2011) 1.36
Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol (2012) 1.29
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythm Electrophysiol (2012) 1.26
The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int (2014) 1.25
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer (2013) 1.23
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2005) 1.21
Living donor liver transplantation. J Hepatol (2003) 1.18
Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology (2011) 1.18
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer (2012) 1.14
Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology (2004) 1.13
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc Natl Acad Sci U S A (2006) 1.12
Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases. Ann Surg (2004) 1.12
The problem of single parent/child paternity analysis--practical results involving 336 children and 348 unrelated men. Forensic Sci Int (2005) 1.11
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (2013) 1.11
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Clin Ther (2003) 1.10
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Int J Cancer (2013) 1.09
Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes. FASEB J (2002) 1.07
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One (2010) 1.07
Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology (2003) 1.02
Age- and sex-related changes of humeral head microarchitecture: histomorphometric analysis of 60 human specimens. J Orthop Res (2010) 0.98
Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int (2008) 0.98
Living donor nephrectomy: flank incision versus anterior vertical mini-incision. Transplantation (2004) 0.95
Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int (2006) 0.95
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2004) 0.95
Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. Liver Transpl (2009) 0.95
Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant (2004) 0.94
Attention and executive functioning deficits in liver-transplanted children. Transplantation (2010) 0.94
Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection. BMC Gastroenterol (2014) 0.94
Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization. Biochem Biophys Res Commun (2002) 0.93
Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury. Neurosurg Rev (2014) 0.91
One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future. Ann Surg (2004) 0.91
The EVIDENT-trial: protocol and rationale of a multicenter randomized controlled trial testing the effectiveness of an online-based psychological intervention. BMC Psychiatry (2013) 0.91
Split liver transplantation and risk to the adult recipient: analysis using matched pairs. J Am Coll Surg (2002) 0.90
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2013) 0.90
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int (2006) 0.90
3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantation. Eur Radiol (2003) 0.90
Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102. Biochem J (2009) 0.90
Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis. PLoS One (2013) 0.90
Proper estimation of blood loss on scene of trauma: tool or tale? J Trauma (2010) 0.89
Avoid "All-Touch" by Hybrid ALPPS to Achieve Oncological Efficacy. Ann Surg (2016) 0.88
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer. Ann Surg (2015) 0.88
Immediate postoperative intensive care treatment of pediatric combined liver-kidney transplantation: outcome and prognostic factors. Transplantation (2011) 0.87
Menopausal hormone therapy and risk of clinical breast cancer subtypes. Cancer Epidemiol Biomarkers Prev (2009) 0.87
The degree of articular depression as a predictor of soft-tissue injuries in tibial plateau fracture. Knee Surg Sports Traumatol Arthrosc (2012) 0.86
Selection of a secretion-incompetent mutant in the serum of a patient with severe hepatitis B. Gastroenterology (2003) 0.86
Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Rev Med Virol (2012) 0.86
Neonates with severe infantile hepatic hemangioendothelioma: limitations of liver transplantation. Pediatr Transplant (2008) 0.86
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl (2010) 0.85
Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient. Transplantation (2010) 0.85
Sex differences in the morphological failure patterns following hip resurfacing arthroplasty. BMC Med (2011) 0.85
Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment. Clin Infect Dis (2002) 0.85
10-year results following impaction bone grafting of major bone defects in 29 rotational and hinged knee revision arthroplasties: a follow-up of a previous report. Acta Orthop (2013) 0.85
Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation. Platelets (2010) 0.85
Long-term outcome of split liver transplantation using right extended grafts in adulthood: A matched pair analysis. Ann Surg (2006) 0.85
Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation. Transplantation (2015) 0.85
Cytogenetics of extramedullary manifestations in multiple myeloma. Br J Haematol (2013) 0.84
Enzymatic production and complete nuclear magnetic resonance assignment of the sugar lactulose. J Agric Food Chem (2004) 0.84
High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Transpl Int (2012) 0.84
Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem (2007) 0.84
A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transpl (2006) 0.84
Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options. Transpl Int (2009) 0.84